Immunoconjugates and bispecific antibodies: Trends in therapeutic success and commercial focus

Michael S Kinch,Zachary Kraft,Tyler Schwartz

Drug Discovery Today（2023）

引用 1|浏览10

暂无评分

摘要

•Immunoconjugates and bispecific antibodies are rapidly gainin in popularity.•Most immunoconjugates and bsAbs are developed for the treatment of cancer.•A trend towards fast-followers is occurring for immunoconjugates and bsAbs.•The number of organizations developing these therapeutics is expanding rapidly.

查看译文

关键词

monoclonal antibodies,clinical trials,bispecific,antibody–drug conjugate

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要